CLINAM 5/2012 with ETPN

The European Summit for Clinical Nanomedicine

Basel, Switzerland, Monday, May 7, 09.00 h – Wednesday, May 9, 2012, 17.00 h

Full Preliminary Programme

Pre- Meetings on Sunday, May 6, 2012 • General Assembly of the European Society for Nanomedicine (3 pm) • Meeting of the International Society for Nanomedicine (5.00 pm) • Welcome Dinner for arrived speakers (7.45 pm)

Main Sections of the Summit

  • 5th European CLINAM Conference for Clinical Nanomedicine: Focus Day: “The Interplay of Molecular Imaging and Diagnostics with Targeted Therapies”
  • 3rd ETP Nanomedicine Brokerage Day
  • 2nd ETP Nanomedicine Policy – Industry Table
  • 3rd EU FP7 Nanomedicine Projects Meeting
  • 5th Nanomedicine University Village & Foyer Exhibition

 

Venue: congress center | basel ,  Messeplatz 21, Basel, Switzerland

Largest Nanomedicine Gathering in Europe

The European Foundation for Clinical Nanomedicine (CLINAM) and the European Technology Platform on Nanomedicine organise the European Summit for Clinical Nanomedicine 2012. It is the largest platform in Europe for discussing all facets of Nanomedicine. Here you will find the clinicians, the device engineers, the strategy developers, the regulators as well as researchers and industry presenting late breaking and ongoing clinical trials. Multiple organisations make this meeting a highlight event where the interdisciplinary mix of experts will illuminate the advancements and novel results in all fields of this complex discipline. Five European Nanomedicine research projects funded under the 7th Framework Programme in the area of Drug Delivery, Nanodiagnostics, Regenerative Medicine and Bio-artificial Organs will be presented and discussed in Basel.

CLINAM 2012 - the Summit Shaping the Future of Medicine and Tackling the Unresolved Medical Problems

• Bringing together leading edge nanotechnologies based technologies, biomedical and clinical knowledge

• Presenting clinical trials that apply Nanomedicine to patients

• Facing the challenges in regulation, toxicology, ethics, and sustainability in medicine

• Exploring translation pathways from research to industrial products

• Identifying the strategic instruments in Nanomedicine for the next decade

See more: go to “CONFERENCE”

 

The Foundation

The European Foundation for Clinical Nanomedicine is a non-profit institution aiming at advancing medicine to the benefit of individuals and society through the application of nanoscience. Aiming at prevention, diagnosis, and therapy through nanomedicine as well as at exploration of its implications, the Foundation reaches its goals through support of clinically focussed research and of interaction and information flow between clinicians, researchers, the public, and other stakeholders. The recognition of the large future impact of nanoscience on medicine and the observed rapid advance of medical applications of nanoscience have been the main reasons for the creation of the Foundation.

Nanotechnology for Medicine

Nanotechnology is generally considered as the key technology of the 21st century. It is an interdisciplinary scientific field focusing on methods, materials, and tools on the nanometer scale, i.e. one millionth of a millimeter. The application of this science to medicine seeks to benefit patients by providing prevention, early diagnosis, and effective treatment for prevalent, for disabling, and for currently incurable medical conditions.